Objects
Russell, Cecilia C., Stevens, Andrew, McCluskey, Adam, Pi, Hongfei, Khazandi, Manouchehr, Ogunniyi, Abiodun D., Young, Kelly A., Baker, Jennifer R., McCluskey, Siobhann N., Page, Stephen W., Trott, Darren J.. Wiley-VCH Verlag GmbH & Co. KGaA; 2018. Gram-Positive and Gram-Negative Antibiotic Activity of Asymmetric and Monomeric Robenidine Analogues.
Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly, McCluskey, Adam, Garg, Sanjay, Page, Stephen W., Trott, Darren J., Ogunniyi, Abiodun D.. MDPI AG; 2022. Impact of a Novel Anticoccidial Analogue on Systemic Staphylococcus aureus Infection in a Bioluminescent Mouse Model.
Pi, Hongfei, Nguyen, Hang Thi, Venter, Henrietta, Boileau, Alexandra R., Woolford, Lucy, Garg, Sanjay, Page, Stephen W., Russell, Cecilia C., Baker, Jennifer R., McCluskey, Adam, O'Donovan, Lisa A., Trott, Darren J., Ogunniyi, Abiodun D.. Frontiers Research Foundation; 2020. In vitro activity of robenidine analog NCL195 in combination with outer membrane permeabilizers against gram-negative bacterial pathogens and impact on systemic gram-positive bacterial infection in mice.
Khazandi, Manouchehr, Pi, Hongfei, Chan, Wei Yee, Ogunniyi, Abiodun David, Sim, Jowenna Xiao Feng, Venter, Henrietta, Garg, Sanjay, Page, Stephen W., Hill, Peter B., McCluskey, Adam, Trott, Darren J.. Frontiers Research Foundation; 2019. In vitro antimicrobial activity of Robenidine, Ethylenediaminetetraacetic acid and Polymyxin B Nonapeptide against important human and veterinary pathogens.
Stevens, Andrew J., Abraham, Rebecca, Young, Kelly A., Russell, Cecilia C., McCluskey, Siobhann N., Baker, Jennifer R., Rusdi, Bertha, Page, Stephen W., O'Handley, Ryan, O'Dea, Mark, Abraham, Sam, McCluskey, Adam. Wiley-Blackwell; 2022. Antigiardial Activity of Novel Guanidine Compounds.
Pi, Hongfei, Venter, Henrietta, Russell, Cecilia C., Young, Kelly A., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodum D., Trott, Darren J.. MDPI; 2022. In Vitro Activity of Robenidine Analogues NCL259 and NCL265 against Gram-Negative Pathogens.
Nguyen, Hang Thi, O'Donovan, Lisa A., Venter, Henrietta, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Trott, Darren J., Ogunniyi, Abiodun D.. MDPI AG; 2021. Comparison of two transmission electron microscopy methods to visualize drug-induced alterations of gram-negative bacterial morphology.
Abraham, Rebecca J., Abraham, Sam, Stevens, Andrew J., Page, Stephen W., McCluskey, Adam, Trott, Darren J., O'Handley, Ryan M.. Elsevier; 2019. Aminoguanidines: new leads for treatment of Giardia duodenalis infection.
Nguyen, Hang Thi, Venter, Henrietta, Veltman, Tania, Williams, Ruth, O'Donovan, Lisa Anne, Russell, Cecilia C., McCluskey, Adam, Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.. Elsevier BV; 2021. In vitro synergistic activity of NCL195 in combination with colistin against Gram-negative bacterial pathogens.
Ogunniyi, Abiodun D., Khazandi, Manouchehr, Laven-Law, Geraldine, Totoli, Eliane G., Salgado, Hérida R., Pi, Hongfei, Coombs, Geoffrey W., Shinabarger, Dean L., Turnidge, John D., Paton, James C., McCluskey, Adam, Trott, Darren J., Stevens, Andrew J., Sims, Sarah K., Page, Stephen W., Garg, Sanjay, Venter, Henrietta, Powell, Andrew, White, Karen, Petrovski, Kiro R.. Public Library of Science (PLoS); 2017. Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent.
Russell, Cecillia C., Stevens, Andrew, McCluskey, Adam, Young, Kelly A., Baker, Jennifer R., McCluskey, Siobhann N., Khazandi, Manouchehr, Pi, Hongfei, Ogunniyi, Abiodun, Page, Stephen W., Trott, Darren J.. Wiley - V C H Verlag GmbH & Co. KGaA; 2019. Discovery of 4,6-bis(2-((E)-benzylidene)hydrazinyl)pyrimidin-2-amine with antibiotic activity.
Abraham, Rebecca J., Stevens, Andrew J., O'Handley, Ryan, McCluskey, Adam, Trott, Darren J., Young, Kelly A., Russell, Cecilia, Qvist, Anastasia, Khazandi, Manouchehr, Wong, Hui San, Abraham, Sam, Ogunniyi, Abiodun D., Page, Stephen W.. American Chemical Society; 2016. Robenidine analogues as gram-positive antibacterial agents.
Nguyen, Hang Thi, Venter, Henrietta, Woolford, Lucy, Young, Kelly A., Mccluskey, Adam, Garg, Sanjay, Sapula, Sylvia S., Page, Stephen W., Ogunniyi, Abiodun David, Trott, Darren J.. American Society for Microbiology; 2023. Oral administration of a 2-aminopyrimidine robenidine analogue (NCL195) significantly reduces Staphylococcus aureus infection and reduces Escherichia coli infection in combination with sub-inhibitory colistin concentrations in a bioluminescent mouse model.